Pathstone Holdings’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Buy
38,137
+3,910
+11% +$43.6K ﹤0.01% 2045
2026
Q1
$371K Buy
34,227
+100
+0.3% +$856 ﹤0.01% 1885
2025
Q4
$209K Buy
34,127
+8,694
+34% +$51.9K ﹤0.01% 2093
2025
Q3
$132K Buy
25,433
+4,639
+22% +$26.7K ﹤0.01% 2251
2025
Q2
$123K Sell
20,794
-7,993
-28% -$48.1K ﹤0.01% 2095
2025
Q1
$237K Sell
28,787
-2,820
-9% -$23.7K ﹤0.01% 2014
2024
Q4
$261K Buy
31,607
+12,372
+64% +$99.2K ﹤0.01% 2027
2024
Q3
$147K Sell
19,235
-6,246
-25% -$57.5K ﹤0.01% 2219
2024
Q2
$264K Sell
25,481
-832
-3% -$9.12K ﹤0.01% 2011
2024
Q1
$314K Buy
26,313
+930
+4% +$10.3K ﹤0.01% 1922
2023
Q4
$274K Buy
+25,383
New +$309K ﹤0.01% 1888

Other funds holding PTEN

Pathstone Holdings's PTEN Position: Q2 2026 in Review

Pathstone Holdings increased its Patterson-UTI (PTEN) stake by 11% in Q2 2026, buying an estimated $43.6K and bringing the position to 38,137 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

Pathstone Holdings first reported a position in PTEN in Q4 2023 and has held it in 11 quarters since. The position peaked at $371K in Q1 2026. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Pathstone Holdings held 38,137 shares of Patterson-UTI worth $350K as of Q2 2026.
  • Pathstone Holdings bought 3,910 Patterson-UTI shares in Q2 2026, an estimated $43.6K.
  • Patterson-UTI made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2045 holding.
  • Pathstone Holdings first reported a position in Patterson-UTI in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Patterson-UTI position peaked at $371K in Q1 2026.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.